Overview

Evaluating the Role of Pregabalin in Reducing Opioid Requirement in Spinal Fusion Surgeries of Two or More Vertebrae

Status:
Terminated
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
To see if the administration of 3 dosses of pregabalin (1 dose preoperative, 2 doses postoperative) will reduce the postoperative opiate requirements of patients undergoing spinal fusion surgeries of two or more vertebrae.
Phase:
Phase 3
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Pregabalin